MEDI Fact Sheet: Harbor Health Care ETF
Share
$34.93
close, Nov 18, 2026
Over the year to Nov 18, 2026, MEDI returned +10.4% in total and charged 0.80% a year.
- 1-year total return
- +10.4%
- to Nov 18, 2026
- Expense ratio
- 0.80%
- a year
- Net assets
- $42m
- on Nov 16, 2026
- Net flow, last 3 trading days
- −$1.8m
- daily basis to Nov 16, 2026
Growth of $10,000, 1 year
MEDI $11,040 +10.4% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month+7.2%
3 months−1.9%
Year to date+11.1%
1 year+10.4%
3 years+60.0%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
Eli Lilly & Co20.78%
Ascendis Pharma A/S13.61%
Gilead Sciences Inc5.10%
Rhythm Pharmaceuticals Inc4.02%
AbbVie Inc3.09%
Intuitive Surgical Inc2.83%
Cencora Inc2.75%
Revolution Medicines Inc2.54%
Insmed Inc2.52%
Merck & Co Inc2.47%
MEDI top ten by weight, 59.7% of the fund, of its 44 equity positions, from the holdings filed for Jul 31, 2026.
Facts
Equity fund · Actively managed · First traded Nov 17, 2022 · Benchmark Its own holdings, as of Jul 31, 2026; its prospectus names no index it tracks